Late HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: A single centre observational cohort study

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Shrosbree, Julia ^a   Campbell, Lucy J ^b   Ibrahim, Fowzia ^b   Hopkins, Phillip ^a   Vizcaychipi, Marcela ^c   Strachan, Stephanie ^a   Post, Frank A ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Antiretroviral therapy; cART; HIV; ICU; Immunodeficiency; Intensive care; Late

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DELAYED DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PNEUMOCYSTIS PNEUMONIA; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; TUBERCULOSIS; VIRUS DIAGNOSIS;

ADULT; COHORT STUDIES; DELAYED DIAGNOSIS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HOSPITALIZATION; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LONDON; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84872353056     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-23     Document Type: Article

References (31)

1. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, Knysz B, Dietrich M, Phillips AN, Lundgren JD. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003, 362(9377):22-29. 10.1016/S0140-6736(03)13802-0, 12853195.
2. Fisher M. Late diagnosis of HIV infection: major consequences and missed opportunities. Curr Opin Infect Dis 2008, 21(1):1-3. 10.1097/QCO.0b013e3282f2d8fb, 18192778.
3. Sabin CA, Schwenk A, Johnson MA, Gazzard B, Fisher M, Walsh J, Orkin C, Hill T, Gilson R, Porter K, et al. Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS 2010, 24(5):723-727.
4. Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, Girardi E, Johnson M, Kirk O, Lundgren J, et al. Late presentation of HIV infection: a consensus definition. HIV Med 2011, 12(1):61-64. 10.1111/j.1468-1293.2010.00857.x, 20561080.
5. May M, Sterne JA, Sabin C, Costagliola D, Justice AC, Thiebaut R, Gill J, Phillips A, Reiss P, Hogg R, et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS 2007, 21(9):1185-1197. 3460385, 17502729.
6. May M, Gompels M, Delpech V, Porter K, Post F, Johnson M, Dunn D, Palfreeman A, Gilson R, Gazzard B, et al. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011, 343:d6016. 10.1136/bmj.d6016, 3191202, 21990260.
7. Krentz HB, Auld MC, Gill MJ. The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med 2004, 5(2):93-98. 10.1111/j.1468-1293.2004.00193.x, 15012648.
8. Fleishman JA, Yehia BR, Moore RD, Gebo KA. The economic burden of late entry into medical care for patients with HIV infection. Med Care 2010, 48(12):1071-1079. 10.1097/MLR.0b013e3181f81c4a, 3022268, 21063228.
9. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006, 20(10):1447-1450. 10.1097/01.aids.0000233579.79714.8d, 16791020.
10. Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007, 46(Suppl 1):S3-S8. 10.1097/01.qai.0000286597.57066.2b, 17713423.
11. Sullivan AK, Curtis H, Sabin CA, Johnson MA. Newly diagnosed HIV infections: review in UK and Ireland. BMJ 2005, 330(7503):1301-1302. 10.1136/bmj.38398.590602.E0, 558202, 15894552.
12. Akgun KM, Pisani M, Crothers K. The changing epidemiology of HIV-infected patients in the intensive care unit. J Intensive Care Med 2011, 26(3):151-164. 10.1177/0885066610387996, 21436170.
13. Dickson SJ, Batson S, Copas AJ, Edwards SG, Singer M, Miller RF. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax 2007, 62(11):964-968. 10.1136/thx.2006.072256, 2117109, 17517829.
14. Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004, 18(10):1429-1433. 10.1097/01.aids.0000131301.55204.a7, 15199319.
15. Palacios R, Hidalgo A, Reina C, de la Torre M, Marquez M, Santos J. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit. HIV Med 2006, 7(3):193-196. 10.1111/j.1468-1293.2006.00353.x, 16494634.
16. Croda J, Croda MG, Neves A, De Sousa dos Santos S. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med 2009, 37(5):1605-1611. 10.1097/CCM.0b013e31819da8c7, 19325488.
17. Adlakha A, Pavlou M, Walker DA, Copas AJ, Dufty N, Batson S, Edwards SG, Singer M, Miller RF. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy. Int J STD AIDS 2011, 22(9):498-504. 10.1258/ijsa.2011.010496, 21890545.
18. van Lelyveld SF, Wind CM, Mudrikova T, van Leeuwen HJ, de Lange DW, Hoepelman AI. Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit. Eur J Clin Microbiol Infect Dis 2011, 66(4):890-895.
19. Powell K, Davis JL, Morris AM, Chi A, Bensley MR, Huang L. Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest 2009, 135(1):11-17. 10.1378/chest.08-0980, 2742310, 18719058.
20. Khouli H, Afrasiabi A, Shibli M, Hajal R, Barrett CR, Homel P. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med 2005, 20(6):327-333.
21. Ibrahim F, Naftalin C, Cheserem E, Roe J, Campbell LJ, Bansi L, Hendry BM, Sabin C, Post FA. Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure. AIDS 2010, 24(14):2239-2244. 10.1097/QAD.0b013e32833c85d6, 20634665.
22. Roe J, Campbell LJ, Ibrahim F, Hendry BM, Post FA. HIV care and the incidence of acute renal failure. Clin Infect Dis 2008, 47(2):242-249. 10.1086/589296, 18540821.
23. Achhra AC, Amin J, Law MG, Emery S, Gerstoft J, Gordin FM, Vjecha MJ, Neaton JD, Cooper DA. Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients. AIDS 2010, 24(12):1877-1886. 10.1097/QAD.0b013e32833b1b26, 2902669, 20588170.
24. Bansi L, Hughes A, Bhagani S, Mackie NE, Leen C, Levy J, Edwards S, Connolly J, Holt SG, Hendry BM, et al. Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS 2009, 23(18):2517-2521. 10.1097/QAD.0b013e3283320e12, 19752713.
25. Podlekareva D, Mocroft A, Dragsted UB, Ledergerber B, Beniowski M, Lazzarin A, Weber J, Clumeck N, Vetter N, Phillips A, et al. Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study. J Infect Dis 2006, 194(5):633-641. 10.1086/506366, 16897662.
26. Chadborn TR, Baster K, Delpech VC, Sabin CA, Sinka K, Rice BD, Evans BG. No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002). AIDS 2005, 19(5):513-520. 10.1097/01.aids.0000162340.43310.08, 15764857.
27. Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004). AIDS 2006, 20(18):2371-2379. 10.1097/QAD.0b013e32801138f7, 17117024.
28. Waters L, Fisher M, Anderson J, Wood C, Delpech V, Hill T, Walsh J, Orkin C, Bansi L, Gompels M, et al. Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med 2011, 12(5):289-298. 10.1111/j.1468-1293.2010.00881.x, 21054749.
29. Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009, 373(9672):1352-1363. 2670965, 19361855.
30. Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS 2008, 22(18):2409-2418. 10.1097/QAD.0b013e3283174636, 2679976, 19005264.
31. Scourfield A, Jackson A, Nelson M. Will earlier diagnosis of HIV infection in late presenters reduce the frequency of serious opportunistic infections?. HIV Med 2011, 12(7):449-450. 10.1111/j.1468-1293.2011.00931.x, 21729231.